Oi S.A. (NYSE;OIBR) hereby announces to its shareholders and the market in general that it filed the preliminary prospectus supplement relating to the Offering with the U.S. Securities and Exchange Commission on the date hereof. Oi SA (ADR) (NYSE:OIBR) shares after opening at $1.37 moved to $1.37 on last trade day and at the end of the day closed at $1.26. Company price to sales ratio in past twelve months was calculated as 0.15. Oi SA (ADR) (NYSE:OIBR) showed a negative weekly performance of -6.67%.
In-flight connectivity provider, Gogo Inc. (NASDAQ:GOGO) signed a technical services agreement with the aerospace behemoth The Boeing Co. in view of the prospect of installing Gogo in-flight connectivity technology in Boeing’s aircraft. Gogo Inc. (NASDAQ:GOGO) shares fell -7.70% in last trading session and ended the day on $16.79.GOGO return on equity ratio is recorded as -183.40% and its return on assets is -28.50%.
Galena Biopharma Inc. (NASDAQ:GALE), which is a mid-cap drug maker has seen its share price come under severe pressure of the bear market, ever since it reported on 17th March, that it has received communication from the SEC on the firm being investigated for breach of public trading rules. Galena Biopharma Inc. (NASDAQ:GALE) shares moved down -8.74% in last trading session and was closed at $1.88, while trading in range of $1.82 – $2.10. Galena Biopharma Inc. (NASDAQ:GALE) year to date (YTD) performance is -62.10%.
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) on 7 April presented new preclinical data demonstrating the ability of its Toll-like receptor (TLR) antagonist, IMO-8400, to inhibit the survival and proliferation of B-cell lymphoma cells harboring the oncogenic MYD88 L265P genetic mutation. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) weekly performance is -21.82%. On last trading day company shares ended up $2.83. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) distance from 50-day simple moving average (SMA50) is -43.92%. Analysts mean target price for the company is $7.00.
Leave a Reply